These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
912 related items for PubMed ID: 25320286
1. Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort. Guglielmetti L, Le Dû D, Jachym M, Henry B, Martin D, Caumes E, Veziris N, Métivier N, Robert J, MDR-TB Management Group of the French National Reference Center for Mycobacteria and the Physicians of the French MDR-TB Cohort. Clin Infect Dis; 2015 Jan 15; 60(2):188-94. PubMed ID: 25320286 [Abstract] [Full Text] [Related]
5. Compassionate use of bedaquiline in the treatment of pulmonary XDR-TB. Danckers M, Lesko MB, Adamson R, Leibert E. Int J Tuberc Lung Dis; 2014 Dec 15; 18(12):1522-3. PubMed ID: 25517823 [No Abstract] [Full Text] [Related]
6. Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study. Borisov SE, Dheda K, Enwerem M, Romero Leyet R, D'Ambrosio L, Centis R, Sotgiu G, Tiberi S, Alffenaar JW, Maryandyshev A, Belilovski E, Ganatra S, Skrahina A, Akkerman O, Aleksa A, Amale R, Artsukevich J, Bruchfeld J, Caminero JA, Carpena Martinez I, Codecasa L, Dalcolmo M, Denholm J, Douglas P, Duarte R, Esmail A, Fadul M, Filippov A, Davies Forsman L, Gaga M, Garcia-Fuertes JA, García-García JM, Gualano G, Jonsson J, Kunst H, Lau JS, Lazaro Mastrapa B, Teran Troya JL, Manga S, Manika K, González Montaner P, Mullerpattan J, Oelofse S, Ortelli M, Palmero DJ, Palmieri F, Papalia A, Papavasileiou A, Payen MC, Pontali E, Robalo Cordeiro C, Saderi L, Sadutshang TD, Sanukevich T, Solodovnikova V, Spanevello A, Topgyal S, Toscanini F, Tramontana AR, Udwadia ZF, Viggiani P, White V, Zumla A, Migliori GB. Eur Respir J; 2017 May 15; 49(5):. PubMed ID: 28529205 [Abstract] [Full Text] [Related]
7. Multidrug-resistant tuberculosis and culture conversion with bedaquiline. Diacon AH, Pym A, Grobusch MP, de los Rios JM, Gotuzzo E, Vasilyeva I, Leimane V, Andries K, Bakare N, De Marez T, Haxaire-Theeuwes M, Lounis N, Meyvisch P, De Paepe E, van Heeswijk RP, Dannemann B, TMC207-C208 Study Group. N Engl J Med; 2014 Aug 21; 371(8):723-32. PubMed ID: 25140958 [Abstract] [Full Text] [Related]
8. Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis. Chahine EB, Karaoui LR, Mansour H. Ann Pharmacother; 2014 Jan 21; 48(1):107-15. PubMed ID: 24259600 [Abstract] [Full Text] [Related]
10. Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis. Guglielmetti L, Jaspard M, Le Dû D, Lachâtre M, Marigot-Outtandy D, Bernard C, Veziris N, Robert J, Yazdanpanah Y, Caumes E, Fréchet-Jachym M, French MDR-TB Management Group. Eur Respir J; 2017 Mar 21; 49(3):. PubMed ID: 28182570 [Abstract] [Full Text] [Related]
13. Bedaquiline: a novel antitubercular agent for the treatment of multidrug-resistant tuberculosis. Worley MV, Estrada SJ. Pharmacotherapy; 2014 Nov 21; 34(11):1187-97. PubMed ID: 25203970 [Abstract] [Full Text] [Related]
14. Initial experience of bedaquiline use in a series of drug-resistant tuberculosis patients from India. Udwadia ZF, Amale RA, Mullerpattan JB. Int J Tuberc Lung Dis; 2014 Nov 21; 18(11):1315-8. PubMed ID: 25299863 [Abstract] [Full Text] [Related]
17. Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review. Migliori GB, Pontali E, Sotgiu G, Centis R, D'Ambrosio L, Tiberi S, Tadolini M, Esposito S. Int J Mol Sci; 2017 Feb 07; 18(2):. PubMed ID: 28178199 [Abstract] [Full Text] [Related]